TITLE

Drug counterfeiting: A rising public health concern

AUTHOR(S)

Buzzeo, Ronald W.

PUB. DATE

April 2005

SOURCE

Drug Topics;4/18/2005, Vol. 149 Issue 8, p19

SOURCE TYPE

Trade Publication

DOC. TYPE

Article

ABSTRACT

This article shares the author's views on the issue regarding drug counterfeiting in the U.S. He notes that the U.S. Food and Drug Administration sees the rise in counterfeit drugs as a serious health concern that not only undermines the legal drug distribution system, but also could erode consumer confidence in the pharmaceutical industry. In this connection, the Verified-Accredited Wholesale Distributors (VAWD) program accredits wholesale distributors of prescription medications and medical devices and helps protect the public from the threat of counterfeit drugs affecting the U.S. drug supply. VAWD accreditation will provide assurance that the distributor will operate legitimately, is validly licensed, and is employing security and best practices for safely distributing prescription drugs from manufacturers to pharmacies and other institutions.

ACCESSION #

16871042

Tags: DRUGS;  PRODUCT counterfeiting;  COUNTERFEITS & counterfeiting;  PHARMACEUTICAL policy;  PHARMACEUTICAL industry

 

Related Articles

• Trojan Drugs: Counterfeit and Mislabeled Pharmaceuticals in the Legitimate Market. deKieffer, Donald // American Journal of Law & Medicine;2006, Vol. 32 Issue 2/3, p325 

  The article focuses on the practical and legal dimensions of trade in Trojan drugs. Several reported incidents of counterfeit and mislabeled drugs being sold by legitimate pharmacies in the U.S. with the extent of counterfeits in the legitimate market however, is unknown. Despite elaborate...

• Counterfeit and substandard medicines.  // WHO Drug Information;2008, Vol. 22 Issue 4, p276 

  The article focuses on the concern over the spread of substandard and counterfeit medicines worldwide, with emphasis on the efforts of health organizations in Latin America to fight this problem. It notes the formation of the Pan American Network for Drug Regulation Harmonization (PANDRH)...

• Fade to Black: Importation and Counterfeit Drugs. Liang, Bryan A. // American Journal of Law & Medicine;2006, Vol. 32 Issue 2/3, p279 

  The article focuses on the introduction and peddling of counterfeit drugs through vulnerabilities in the drug distribution. It reviews some of the issues associated with the counterfeit drugs and drug importation and reviews the characteristics of counterfeit drugs including their scope, known...

• Counterfeit Drugs, One Click Away. Mutterperl, Mark; Longbottom, Bruce; Chemcham, Chehrazade; Parise, Jessica // Pharmaceutical Executive;Sep2007, Vol. 27 Issue 9, p36 

  The article discusses on the issue of counterfeit drugs and pharmaceuticals in the Internet. According to the authors, counterfeit drugs are drugs that look like branded or generic medicines but have deliberately and fraudulently mislabeled with respect to their source of origin. They contend...

• State pedigree laws running into some barriers. Blank, Dennis // Drug Topics;7/11/2005, Vol. 149 Issue 13, p37 

  The article discusses barriers to the implementation of state pedigree laws, legislation that requires a paper trail on prescription drugs to control counterfeiting in the United States. There are growing signs of resistance and complaints that it will be very costly to install a uniform...

• Importation still cause for counterfeit drug alarm. Johnsen, Michael // Drug Store News;10/24/2005, Vol. 27 Issue 14, p17 

  Reports on the growth of counterfeit medicines in the U.S. Pharmaceutical distribution system of the U.S.; Debate surrounding the importation of drugs into the U.S.

• Counterfeit Drugs Pose Threat.  // Journal of Psychosocial Nursing & Mental Health Services;Apr2005, Vol. 43 Issue 4, p14 

  Highlights the second Global Forum on Pharmaceutical AntiCounterfeiting held on March 15-17, 2005 in Paris, France. Role of health care professionals in protecting patients from substandard and even counterfeit medications; Significance of the event; Factor which is key in preventing...

• No easy answer to counterfeit Rxs, lament regulators. Otrompke, John // Drug Topics;6/7/2004, Vol. 148 Issue 11, p70 

  The U.S. pharmaceutical industry is trying to overt covert methods to foil drug counterfeiting, but each strategy has its own drawbacks. That is one conclusion drawn from a Food and Drug Law Institute program on drug counterfeiting, held in Chicago, Illinois on May 2004. As recent price...

• Fighting back against counterfeit drugs.  // Pharmaceutical Technology Europe;Nov2005, Vol. 17 Issue 11, p14 

  Focuses on the aim of the International Council of Nurses and the International Federation of Pharmaceutical Manufacturers & Associations to inform people of the dangers of counterfeit drugs in Europe. Efforts of the organizations to harness their worldwide member networks with the...

Read the Article